Aims West Syndrome is an age dependent epileptic encephalopathy with variable therapeutic response. Worldwide, there is scarce data on magnitude and effect of treatment lag on therapeutic response ...

Cannabidiol is under clinical development by Jazz Pharmaceuticals and currently in Phase III for Infantile Spasm (West Syndrome). According to GlobalData, Phase III drugs for Infantile Spasm (West ...

According to the reports, the deceased minor was admitted to the hospital on January and was undergoing treatment. He had ...

Blarcamesine hydrochloride is under clinical development by Anavex Life Sciences and currently in Phase I for Infantile Spasm (West Syndrome). According to GlobalData, Phase I drugs for Infantile ...